Therapy Areas: Vaccines
Novartis' Switzerland fill-and-finish facility to bottle over 50 million doses of BioNTech's COVID-19 vaccine
23 June 2021 -

Swiss multinational pharmaceutical company Novartis (SWX:NOVN) plans to bottle over 50 million doses of BioNTech's (Nasdaq:BNTX) COVID-19 vaccine in 2021, Reuters news agency reported on Wednesday.

This manufacturing will be done at Novartis' Stein, Switzerland fill-and-finish facility.

This comes after the European Union's drug regulator approved the bottling plant.

Login
Username:

Password:


Related Headlines